Model‐EyeD: Harnessing the potential of the eye as a biomarker for Alzheimer’s disease and related dementias

Background Disease‐modifying treatments for Alzheimer’s disease and related dementias (ADRD) will be most effective early in the disease process. Clinical use of these therapies will require practical, widely accessible biomarkers. Plasma‐based protein biomarkers hold promise for identifying core AD...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer's & dementia 2023-12, Vol.19 (S15), p.n/a
Hauptverfasser:	Howell, Gareth R, Marola, Olivia J, Maclean, Michael, Cossette, Travis L, Hewes, Amanda, Morgan, James, Singer, Cliff, Risacher, Shannon L., Onos, Kristen D, Reagan, Alaina M
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!